EL7.AI
Strategy BuilderCOT DataAdvanced NewsResearchNewEarnings CalendarEconomic Calendar
We use cookiesPrivacy Policy
EL7.AIEL7.AI

AI Financial Intelligence
Professional analysis of central bank decisions

© 2026 EL7.AI. All rights reserved.

Markets

  • News
  • Forex
  • Stocks
  • Crypto
  • Gold
  • Commodities
  • Indices
  • ETFs

Analysis

  • Fed
  • ECB
  • BLS
  • COT
  • Economic Calendar

Learn

  • Service Guide
  • Oil

Company

  • About
  • Contact
  • Data Methodology
  • AI Disclosure
  • Pricing
  • Enterprise
  • Terms
  • Privacy
  • Security
  • WhatsApp
Status data is currently unavailable

The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

Home
Stocks
Unilever PLC
EL7 Factor Analysis
How we score this
Overall65
Strong — clearly above market medianContrarianF 7/9Better than 65% of Market stocks, per EL7's model
FactorScoreDistributionValueAvgRank
▸
Valuation
70
11.8x▲17.6xTop tier
▸
Growth
36
-3.8%▼7.1%Bottom tier
▸
Quality
91
—4.5%Top tier
▸
Safety
42
2.4x▲2.6xAround median
▸
Capital Return
46
3.77%▲2.15%Around median
▸
Momentum
45
-11.0%▼2.3%Around median
▸
Sentiment
73
5▲3Top tier
UL

UL Unilever PLC

Unilever PLC · NYSE
Market Closed
61.82
▼ ⁦-0.64%⁩ (-0.40)
Market Cap$133.2B
Beta0.45
52w Low52w High
54.7574.97
Last Week
⁦-0.32%⁩
Last Month
⁦-0.34%⁩
Last 3 Months
⁦+7.03%⁩
Last Year
⁦-11.25%⁩
Fair Value
Current price$62
Analyst target · 5 analysts
$71
⁦+15%⁩
See it undervalued
Range ⁦$39–$81⁩
vs
DCF (estimate)
N/A (negative FCF)

Estimates — analyst targets and a simplified DCF, not investment advice.

Compare in the screener
Premium content

Get Your Premium Account Now

  • Stock Deep Analysis
  • The Advanced News Platform
Recommended
Annual plan
$17/mo
Monthly plan
$29/mo

Analyst Consensus

This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.

Price Target· 5 analysts setting price target
$66.08
⁦+6.9%⁩
Current Price $61.82·Median $71.00
Low
$39.41
High
$81.08
Current price
$61.82
Average target
$66.08
Street summary

Unilever (UL) Price Target Revision Review

Bearish tilt

Unilever stock has seen a notable decline in its average price target of 6.93% over the past thirty days, as the consensus fell from 71 to 66.08. This downward adjustment has narrowed the gap between the current price (64.43) and the consensus target to tight levels, indicating a decline in optimism regarding the potential for strong additional price gains in the near term, despite the number of analysts remaining stable at 5.

As of 2026-08-05
Revisions momentum · 30d
⁦0.0%⁩
Average rating
★ 3.60
Buy
Analyst coverage
5
Buy conviction
60%
Mixed
Target dispersion
67%
Wide
Analyst ratings over time5 analysts rating
3
2
Strong BuyBuyHoldSellStrong Sell
Rating trend — last 12 months4.40 → 3.60
Recent analyst moves
  • = Reiterate2026-07-29
    TD Cowen
    Buy
  • = Reiterate2026-07-06
    Jefferies
    Underperform
  • = Reiterate2026-05-18
    Jefferies
    Underperform
Premium content
Key Financials

Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.

StockSector medianSector averagetypical sector range
MetricValuePosition within sectorVerdict
  • P/E (TTM)
    11.80x
    4.56x36.49x
    Cheap
  • Forward P/E
    —
    —
  • EV / EBITDA
    12.82x
    2.85x22.79x
    Near median
  • FCF Yield
    5.9%
    -38.0%15.3%
    Strong
  • Revenue Growth YoY
    -3.8%
    -16.7%30.5%
    Below average
  • EPS Growth YoY
    67.4%
    -130.3%136.3%
    Strong
  • Gross Margin
    46.9%
    8.9%67.5%
    Above average
  • ROIC
    —
    —
  • Net Debt / EBITDA
    2.38x
    0.60x4.81x
    Low debt
  • Dividend Yield
    3.8%
    0.9%8.3%
    Moderate
  • Payout Ratio
    47.3%
    15.9%176.6%
    Low
  • Altman Z-Score
    —
    —
Financial Analysis
|

Stock Analysis

AI-generated
Based on 2026-07-28 data

Company Overview

Unilever PLC operates in branded consumer goods across the Beauty & Wellbeing, Personal Care, Home Care, and Foods groups. It generates revenue from selling products such as Dove, Vaseline, Sunsilk, Comfort, Cif, Hellmann’s, Knorr, and Liquid I.V. across developed and emerging markets and traditional and digital channels, with investment focused on 30 Power Brands representing 78% of turnover.

In Q2 FY2026, underlying sales rose 5.8%, supported by underlying volume growth of 5.5%, Unilever’s best quarterly volume performance since 2010. Power Brands posted underlying growth of 6.9% and volume growth of 6.8%, while Beauty & Wellbeing grew 8.1%, Personal Care 5.9%, and Home Care 9.1%, compared with only 2.0% for Foods. Emerging markets also grew 8.3%, including 7.4% from volume, India rose 10%, while volume growth in developed markets was 2.8%.

Turnover in H1 FY2026 was approximately €25.6 billion, up 0.5% on a reported basis after currencies reduced growth by 4.9%, and underlying operating profit was €5.2 billion, up 0.9%. The underlying operating margin expanded 10 basis points to 20.3%, despite a 70-basis-point year-on-year decline in gross margin, and underlying earnings per share rose 2.4% to €1.61. For annual comparison, FY2025 financial statements showed revenue of $50.5 billion, gross profit of $23.7 billion, net income of $10.0 billion, and earnings per share of $4.32.

What's Driving the Stock

  • Unilever raised its FY2026 outlook after underlying sales accelerated in Q2 FY2026 to 5.8% and volume growth reached 5.5%; it now expects full-year underlying growth of between 4% and 6% and volume growth of approximately 3%.
  • Power Brands are driving operating momentum, representing 78% of turnover and delivering 6.9% growth in Q2 FY2026, with 15 of 30 brands growing at double-digit rates, supported by Dove, Vaseline, K18, Hourglass, and Comfort.
  • Home Care delivered underlying growth of 9.1% and volume growth of 8.6% in Q2 FY2026, with Cif growing at a double-digit rate and Domestos at a high-single-digit rate, while India recorded its strongest Home Care growth in three years.
  • FIFA World Cup-related marketing activities supported Personal Care across 35 brands, more than 120 markets, and 50 thousand content creators with a combined audience of more than 600 million people, in addition to 180 limited-edition products; in the United States, Unilever regained deodorant market leadership.
  • Portfolio development represents an additional catalyst, as Unilever completed the acquisition of Gruns in June 2026, while management said on July 28, 2026, that the Foods combination with McCormick was proceeding according to plan; the company also targets €6 billion in share buybacks between 2026 and 2029, supported by operating performance and proceeds from the Foods transaction.

Buying & Selling Case

▲ Buying Case4 pts

  • +The bullish case is based on genuine demand growth, as underlying volume rose 5.5% in Q2 FY2026, and average volume growth was 3% over the four quarters ending in that quarter, reducing reliance on price increases alone for growth.
  • +Unilever has strong momentum in emerging markets, where growth reached 8.3% in Q2 FY2026, with India growing 10% and Indonesia 7%, alongside record market-share gains in the hair care and laundry categories in India.
  • +The company combines investment, growth, and efficiency improvements; it maintained brand and marketing spending at 16.1% of turnover, completed an €800 million productivity program ahead of schedule, and increased its underlying operating margin to 20.3% in H1 FY2026.
  • +Cash generation and shareholder returns improved, as free cash flow in H1 FY2026 rose by €0.5 billion to €1.5 billion, the Q2 FY2026 dividend increased by 3%, and a €1.5 billion share buyback program was completed in June 2026.

▼ Selling Case6 pts

  • −

Valuation

Analyst consensus on UL stock is neutral, with an average target of $66.08 and a wide range between $39.41 and $81.08. The average target lies within the 52-week range of $54.75–$74.98 and below its high, while the highest target exceeds that high; this divergence reflects the balance between volume momentum and portfolio improvement versus cost inflation, weakness in Foods, and the possibility of slower volumes as price increases are passed through. The data do not provide a usable earnings multiple, so analyst targets and the 52-week range remain the available valuation anchors.

HoldAnalyst target: $66.08(+6.9%)

Figures in the text are as of 2026-08-26; the live price is shown at the top of the page.

FAQ

What drove Unilever’s growth in Q2 FY2026?

Underlying sales rose 5.8% and underlying volume grew 5.5% in Q2 FY2026, the best quarterly volume growth since 2010. Home Care led with 9.1% growth, followed by Beauty & Wellbeing at 8.1% and Personal Care at 5.9%. Dove, Vaseline, K18, and Comfort helped raise Power Brands growth to 6.9%.

What is Unilever’s outlook for FY2026?

The company expects underlying sales growth of between 4% and 6% in FY2026, with volume growth of approximately 3%. In H2 FY2026, it expects growth of between 4% and 5%, led by pricing, with potential volume sensitivity. It also maintained its expectation for a modest improvement in the underlying operating margin compared with the 20% level in FY2025.

How important is the Foods transaction with McCormick for UL stock?

Management said on July 28, 2026, that the combination of the Foods business with McCormick was progressing according to plan and that more than 100 people from both sides were working on the integration. The transaction aims to transform Unilever into a company more focused on Beauty & Wellbeing, Personal Care, and Home Care. The company expects operating performance and proceeds from the Foods transaction to support €6 billion in share buybacks between 2026 and 2029.

Earnings callEDGAR filings30-day newsInsider activity

Automated analysis for informational purposes only — not investment advice.

Foods remains an operational weakness; the segment grew only 2.0% in Q2 FY2026, and its underlying operating profit declined 4.3% to €1.5 billion in H1, with market-share losses in the U.S. condiments and sauces market due to competition in premium mayonnaise made with alternative oils.
  • −Margins face pressure from inflation and currencies, as gross margin declined 70 basis points year over year in H1 FY2026, and management expects an inflationary impact of approximately €550 million in H2 and approximately €850 million for the full year, with significant concentration in Home Care and emerging markets.
  • −The H2 FY2026 outlook indicates underlying growth slowing to a 4%–5% range compared with 5.8% in Q2 FY2026, with pricing rather than volume expected to drive growth; management acknowledged that passing through price increases could cause volume sensitivity after high cumulative inflation.
  • −Geographic performance is uneven, as Europe declined 0.5% in H1 FY2026 amid weakness in Foods, Beauty & Wellbeing, and Personal Care, while the oral care market remained weak and some legacy Asian brands such as Fair & Lovely and Pond’s declined in markets rapidly shifting toward premium products.
  • −Tax reforms in Brazil could reduce reported sales and cause a temporary reduction in retailer inventories in Q4 FY2026, and the final rates remain subject to notification by Brazilian regulatory authorities; despite an expected positive accounting impact on margins, management expects overall economic profitability to remain unchanged.
  • −Analyst consensus reflects a neutral rather than bullish stance, while the wide target range from $39.41 to $81.08 reveals significant disagreement over the value of the portfolio reshaping and the ability of volume growth to withstand price increases.
  • Does Unilever’s growth depend on emerging markets?

    Emerging markets are a major driver, growing 8.3% in Q2 FY2026, including 7.4% from volume. India grew 10% and Indonesia 7%, while Asia Pacific Africa grew 7.3% in H1 FY2026. In contrast, Europe declined 0.5% during H1, highlighting the importance of emerging markets in offsetting European weakness.

    What are the main operational risks facing Unilever?

    The company faces expected annual inflation of approximately €850 million in FY2026, with particular pressure on Home Care, while gross margin declined 70 basis points in H1. Hellmann’s also lost share in premium mayonnaise categories in the United States, and underlying operating profit in Foods declined 4.3%. In addition, Brazilian tax reforms could cause a temporary reduction in retail inventories in Q4 FY2026.

    How is Unilever redirecting its portfolio toward higher-growth segments?

    Unilever completed the acquisition of Gruns in June 2026 to strengthen its presence in premium and digital supplements, following contributions from Dr. Squatch, Minimalist, and Wild to H1 growth. The company seeks to increase its exposure to wellbeing and prestige beauty, where Paula’s Choice, Hourglass, and Tatcha delivered double-digit growth in Q2 FY2026. At the same time, Power Brands represent 78% of turnover and receive the largest share of brand and marketing investment.